MUSC and Lumera to Develop Antibody Array for Protein Expression Profiling

BOTHELL, Wash.—(BUSINESS WIRE)—April 30, 2007—Lumera Corporation (NASDAQ:LMRA), a leader in the emerging field of nanotechnology, announced today that it has extended its collaboration agreement with the Medical University of South Carolina (MUSC). In partnership with Lumera scientists, MUSC researchers intend to develop an antibody array that will measure the levels and modifications of patient mitochondrial proteins. Under the agreement, Lumera will retain rights to commercialize all jointly developed intellectual property.

Source: Lumera Corp.